Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS)

Journal of Visualized Experiments

Volumn , Issue 67, 2012, Pages

  Thaker, Ameet I ^a   Shaker, Anisa ^a   Suprada Rao, M ^a   Ciorba, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Azoxymethane; Cancer; Cancer biology; Colitis; Crohn's disease; Dextran sulfate sodium; Immunology; Inflammation; Issue 67; Medicine; Physiology

Indexed keywords

EID: 84868266897     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/4100     Document Type: Article

References (23)

1. Ekbom, A., et al. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 323 (18), 1228-33 (1990).
2. Terzic, J., et al. Inflammation and colon cancer. Gastroenterology. 138 (6), 2101-2114 e5 (2010).
3. Ullman, T.A. & Itzkowitz, S.H. Intestinal inflammation and cancer. Gastroenterology. 140 (6), 1807-16 (2011).
4. Okayasu, I., et al. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J. Gastroenterol. Hepatol. 17 (10), 1078-83 (2002).
5. Kanneganti, M., Mino-Kenudson, M., & Mizoguchi, E. Animal models of colitis-associated carcinogenesis. J. Biomed. Biotechnol., 342637 (2011).
6. Neufert, C., Becker, C., & Neurath, M.F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2 (8), 1998-2004 (2007).
7. Tanaka, T., et al. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94 (11), 965-73 (2003).
8. De Robertis, M., et al. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J. Carcinog. 10, 9 (2011).
9. Wirtz, S., et al. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2 (3), 541-6 (2007).
10. Cooper, H.S., et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 69 (2), 238-49 (1993).
11. Becker, C., Fantini, M.C., & Neurath, M.F. High resolution colonoscopy in live mice. Nat. Protoc. 1 (6), 2900-4 (2006).
12. Becker, C., Fantini, M.C., Wirtz, S., Nikolaev, A., Kiesslich, R., Lehr, H.A., Galle, P.R., & Neurath, M.F. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 54, 950-4 (2005).
13. Shaker, A., et al. Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion. J. Clin. Invest. 120 (6), 2081-93 (2010).
14. Boivin, G.P., et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology. 124 (3), 762-77 (2003).
15. Cooper, H.S., et al. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis. 21 (4), 757-68 (2000).
16. Yoshida, Y., et al. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology. 132 (4), 1420-31 (2007).
17. Suzuki, R., et al. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis. 27 (1), 162-9 (2006).
18. Mahler, M., et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274 (3 Pt. 1), G544-51 (1998).
19. Nambiar, P.R., et al. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int. J. Oncol. 22 (1), 145-50 (2003).
20. Tanaka, T. Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog. 8, 5 (2009).
21. Ciorba, M.A., et al. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. J. Immunol. 184 (7), 3907-16 (2010).
22. Kerr, T.A., et al. Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: A poly-A purification solution. Inflamm. Bowel Dis. 18 (2), 344-8 (2012).
23. Tang, Y., et al. Bax is required for resection-induced changes in apoptosis, proliferation, and members of the extrinsic cell death pathways. Gastroenterology. 126 (1), 220-30 (2004).